Browsing Tag
Alastin
3 posts
Galderma targets December 3 board vote as $1.5bn ZO Skin Health acquisition approaches closing
Galderma is proposing the election of Rosalind Brewer and Petra Rumpf to its board while preparing for the departure of Chief Financial Officer Luigi La Corte, who took office in May 2026. The governance changes come as the Swiss dermatology company reports 25.1% constant-currency sales growth, raises annual guidance and prepares to complete its $1.5 billion acquisition of ZO Skin Health. Financial leadership continuity and shareholder approval of the proposed appointments are the immediate priorities.
Inside Galderma’s blockbuster Q3: Why EQT cashed out CHF690m amid record dermatology growth
Find out why EQT exited CHF 690 million in Galderma shares as the dermatology major raised full-year growth guidance after strong Q3 results.
Can Galderma’s Alastin expansion in China reshape the future of perioperative skincare?
Galderma launches Alastin skincare in China, targeting the booming perioperative aesthetics market with science-backed formulations.